SANTA CRUZ, Calif. October 2016 – SomaGenics has been awarded a $1.8M two-year NIH SBIR Phase II grant to further develop its RealSeq®–AC technology for next-generation sequencing (NGS) of small RNAs such as microRNA.
September, 2016 SomaGenics will present recent progress in its RNA detection and sshRNA therapeutics programs in two posters at the OTS Annual Meeting in Montreal, Quebec, September 25-28, 2016.
SomaGenics to present at the 7th non-coding RNA & RNAi Therapeutics conference, Boston, MA on September 14, 2016
Santa Cruz, Calif. September 14, 2016 SomaGenics will present at the 7th non-coding RNA & RNAi Therapeutics conference by Global Technology Community on September 14 in Boston, MA. Dr. Johnston, CEO of SomaGenics, will present progress in SomaGenics’ Wound Healing program and briefly describe RealSeq®-AC, a novel method to prepare small RNA sequencing libraries with greatly reduced bias.